Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
Table 5
Comparison of postoperative data between SPHPT group and ASPHPT group.
Index
SPHPT group n=89
ASPHPT group n=108
P value
Postoperative PTH(uIU/ml) ± SD
31.94 ± 47.55
63.48 ± 192.00
0.031
Postoperative Ca(mmol/L) ± SD
2.42 ± 0.39
2.31 ± 0.23
< 0.0001
Postoperative P(mmol/L) ± SD
0.82 ± 0.26
0.99 ± 0.30
< 0.0001
Lesion diameter(cm)
2.43 ± 1.17
2.07 ± 1.22
0.034
Pathological type
0.053
Parathyroid adenoma
88.76% (79/89)
75.93% (82/108)
0.026
Parathyroid hyperplasia
8.99% (8/89)
20.37% (22/108)
0.029
Parathyroid carcinoma
0.00% (0/89)
1.85% (2/108)
0.502
Parathyroid adenoma with hyperplasia
2.25% (2/89)
1.85% (2/108)
> 0.99
Combined thyroidectomy
< 0.0001
yes
11.24% (10/89)
37.96% (41/108)
no
88.76% (79/89)
62.04% (67/108)
Cure rate of PHPT
96.63% (86/89)
96.30%(104/108)
> 0.99
Recurrence rate of PHPT
1.12% (1/89)
1.85% (2/108)
> 0.99
Incidence of temporary hypocalcemia
13.48% (12/89)
15.74% (17/108)
0.691
a. For multiple lesion tissues, the diameter of the largest lesion tissue was calculated. Abbreviations: SPHPT, symptomatic primary hyperparathyroidism; ASPHPT, asymptomatic primary hyperparathyroidism; PTH, parathyroid hormone; PHPT, primary hyperparathyroidism.
